Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease

Trial Phase 1 Completed Nov. 11, 2024

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Trial Phase 1 Completed Nov. 11, 2024

The Relation Between the Prognosis of Subthalamic Nucleus Deep Brain Stimulation Surgery by Microlesion Effect and Electrode Position

Trial N/A Enrolling by invitation Nov. 11, 2024

Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease

Trial N/A Completed Nov. 7, 2024

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Trial N/A Recruiting Nov. 7, 2024

High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.

Trial N/A Completed Nov. 7, 2024

7.0T Magnetic Resonance Imaging Study of Parkinson's Disease

Trial N/A Recruiting Nov. 7, 2024

Deep Brain Frameless Radiosurgery for Drug Resistant Invalidating Tremor. Dose Escalation Pilot Study

Trial N/A Completed Nov. 7, 2024

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Trial Phase 1 Recruiting Nov. 6, 2024

Exercise & Brain Energetics in PD

Trial N/A Recruiting Nov. 5, 2024

North American Prodromal Synucleinopathy Consortium

Trial N/A Enrolling by invitation Nov. 5, 2024

Objective Assessment of Behavioural Disorders in PD

Trial N/A Active, not recruiting Nov. 5, 2024

Perspectives on Healthcare Access and Equity of People With Parkinson's Disease Identifying as LGBTQ+

Trial N/A Suspended Nov. 5, 2024

Effects of Unblocking the Full Potential of Percept PC IPG

Trial N/A Completed Nov. 3, 2024

Quest to Analyze One Thousand Humans Meditating

Trial N/A Enrolling by invitation Oct. 31, 2024

Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease

Trial Phase 1 Completed Oct. 31, 2024

The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

Trial Phase 1 Recruiting Oct. 31, 2024

STEPS Trial - Spheramine Safety and Efficacy Study

Trial Phase 2 Terminated Oct. 30, 2024

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

Trial N/A Active, not recruiting Oct. 30, 2024

Clinical Trail of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Upper Limb Bradykinesia in Parkinson' Disease' Patients

Trial N/A Enrolling by invitation Oct. 30, 2024